Summary. Ten feral mares free-roaming in Maryland, USA, were inoculated with porcine zonae pellucidae (PZP) 
Introduction
Immunization with porcine zonae pellucidae (PZP) is a promising approach to immunocontraception. This glycoprotein layer is composed of several protein fractions of which a fraction of Mr 55 000, referred to as ZP3, has been identified in the species studied to be the specific zona receptor for sperm recognition and attachment (Sacco et ai, 1984) .
Immunization with PZP has resulted in significant zonae antibody titres and fertility inhibition in a range of laboratory species (Tsunoda & Chang, 1976; Gwatkin et al., 1977) and non-human primates (Gulyas et al., 1983; Sacco et al, 1983a Sacco et al, , 1987 Aitken et al, 1984; Bamezai et ai, 1986; Dunbar et ai, 1989) . Sacco (1977) , Hasegawa et al. (1985) and Trounson et al. (1980) have demon¬ strated that human and porcine zonae share common antigens. In several of these studies, the administration of PZP or purified ZP3 was accompanied by disruption of ovarian function and cyclic endocrine patterns, but, in most cases, normal ovarian function returned over an interval ranging from several cycles to 300 days.
A concern regarding the potential use of PZP, ZP3 or any antigenic epitope of ZP3 in humans or exotic species is the possible permanent loss of fertility or the disruption of normal reproductive endocrine events. Studies in three species have indicated adverse side-effects on ovarian function. Mahi-Brown et al. (1985) found that immunization of bitches led to long-term alterations in oestrous cycles and to abnormal steroid profiles. Immunization of rabbits with PZP also led to disruption of hormone profiles (Wood et al, 1981; Skinner et al, 1983) . Ten baboons immunized with ZP3 showed reduced oestrogen concentrations in plasma and numbers of antral follicles; two of these animals failed to ovulate, and five became amenorrheic by 8 months after immunization (Dunbar et al, 1989) . Liu et al. (1989) 
PZP immunization
The PZP antigen was prepared from porcine ovaries as described by Liu et ai (1989) and stored frozen until used in the field. In 1988 (year 1 of this study), the ten experimental mares were immunized with two or three inoculations of PZP. The schedule of inoculations and the resulting contraceptive effects have been described (Kirkpatrick et ai, 1990a) .
In February, 1989 (year 2 of this study) the ten PZP-treated mares were given a single PZP booster inoculation and the contraceptive efficacy was assessed (Kirkpatrick et ai, 1991 (1988) . Differences in rates of pregnancy between treated and control mares were tested for significance by means of binomial probability distribution (Freedman et ai, 1978) .
Behavioural assessments
Sexual behaviour of treated and control mares was assessed in terms of behavioural oestrous patterns including (i) raised tail when stallions attempted mounting, (ii) eversión of the clitoris, (iii) absence of kicking or biting by the mare during attempted or successful mountings and (iv) copulation, as described by Waring (1983) . The period for which each mare was observed each day ranged from I to 3 h depending upon the duration of the interval between sighting and urination.
Assessment of ovarian function
Unextracted urine samples, collected from the soil, were assayed for oestrone conjugates and non-specific progesterone metabolites by microtitre enzymeimmunoassays. The oestrone conjugate assay has been described (Dads et ai, 1991) and validated for the Equidae (Evans et ai, 1984; Czekala et ai, 1990; Monfort et al., 1991) and reflects plasma oestrogen concentrations (Daels et ai, 1991) ; the inter-and intra-assay coefficients of variation were 11-10 (n = 7) and 3-82% (n = 7), respectively. The lower limit of sensitivity for the assay was 6-25 pg and concentrations of oestrone conjugates in serially diluted urine samples extracted from soil have exhibited parallelism to the standard curve (Kirkpatrick et ai, 1988) . Recovery of 3H-labelled steroid metabolites from the soil has been demonstrated to be >95% (Kirkpatrick et ai, 1988) .
The enzymeimmunoassay for non-specific progesterone metabolites has been described and validated in the Equidae by Kirkpatrick et al. (1990b) and employs monoclonal antibody 1284-1 raised against 205-hydroxyprogesterone (provided by R. Chatterton, Northwestern University). The inter-and intra-assay coefficients of variation were 12-38 (n = 8) and 10-42% (n = 8), respectively. The lower limit of sensitivity was 0075 ng. To account for differences in urine concentrations, all urine samples were assayed for creatinine by the microcolorimetric method of Taussky (1954) (Fig. lc) characterized by an exceptionally high peak in preovulatory oestrone conjugates (11 µg/mg creatinine) coinciding with a nadir in non¬ specific progesterone metabolite (27 ng/mg creatinine) and a subsequent and sustained rise in this urinary metabolite (1-7 µg/mg creatinine). Concentrations of non-specific progesterone metabolites remained above l·0µg/mg creatinine throughout the remainder of the collection period. Urinary oestrone conjugates fell to basal concentrations (15-55 ng/mg creatinine) for 35 days after the ovulatory nadir in non-specific progesterone metabolites and then rose abruptly to l-45pg/mg creatinine, which is a characteristic signal of pregnancy in mares (Evans et al., 1984) . During the first 5 days of urine collection, which coincided with the preovulatory oestrone conjugate increases, M17GL displayed behaviour associated with oestrus and was witnessed being successfully mounted on Days 3-5 of collection. By October, M17GL had a urinary oestrone conjugate concen¬ tration of 31 -3 ng/mg creatinine, indicating that the pregnancy had terminated, a common event in feral 3-year-old mares (Lucas et ai, 1990 (Fig.  2c, d , respectively), but mare M6I did not have the characteristic preovulatory peak in oestrone conjugates.
During two of the increases in oestrone conjugates, on the 10th and 34th days of collection, M6I displayed tail raising and evoked attention from the band stallion, but no mounting was observed. Urine collection with T2BE began in the latter stages of the luteal phase, concentrations of non¬ specific progesterone metabolites falling from 199 ng/mg creatinine to non-detectable concen¬ trations 15 days later. T5AE displayed intermittent behavioural oestrus throughout most of the collection period despite very low oestrone concentrations of conjugates and on one occasion, on Day 27 of collection, was mounted successfully by the band stallion; this mounting coincided with a rapid rise in concentrations of oestrone conjugates from non-detectable to 45 ng/mg creatinine.
The seventh PZP-treated mare (M17G, 8 years old) was pregnant at the time of urine collection and produced a foal on 1 August 1990. This was the only foal produced among the mares treated with a booster inoculation in the second year of this study. The date of parturition indicates an unusually late conception (~2 5 August) for Assateague mares and suggests that her antibody titres had fallen to a concentration which allowed conception. Urinary endocrine data for oestrone conjugates and non-specific progesterone metabolites were consistent with data on plasma hormones for mares in late pregnancy (Ginther, 1979 These alterations in ovarian function are consistent with data from PZP-treated rabbits (Skinner et al, 1983 (Skinner et al, , 1984 , dogs (Mahi-Brown et al, 1985) and baboons (Dunbar et al, 1989) .
The urinary endocrine data and the correlated behavioural observations and events, such as parturition and breeding behaviour for the four control mares, reflect functional ovaries. These data provide an initial view of ovarian function in feral mares which is consistent with data derived from domestic horses based on plasma steroid concentrations (Ginther, 1979) and urinary steroid metabolites (Daels et al, 1991 (Liu et al, 1989) and an acrosome reaction in horse spermatozoa induced by zona pellucida (Arns et ai, 1990) . Kirkpatrick et al. (1990a Kirkpatrick et al. ( , 1991 demonstrated the return of normal fertility rates among feral mares 1-2 years after a single immunization with PZP and, although ovarian endocrine function was not monitored in these two studies, the normal fertility rates indicate that ovulation occurred and that preovulatory oestrogen concentrations were sufficient to elicit breed¬ ing behaviour. Similarly, short-term active immunization of non-human primates led to infertility, but with undetectable or only temporary disruption of ovarian function (Gulyas et al, 1983; Sacco et al, 1983a Sacco et al, , b, 1987 Bamezai et ai, 1986 ).
Zonae antibodies have been shown to bind to the developing follicular zona pellucida as well as to the zona of ovulated ova (Henderson et ai, 1988) . This may indicate that zonae antibodies disrupt some developmentally critical cellular communication between differentiating follicular cells and the growing oocyte (Skinner et ai, 1990) , which ultimately leads to the destruction of a portion or all of the oocyte pool (Skinner et ai, 1984) .
At least three factors may play a significant role in long-term alterations of ovarian function. The duration of contraceptive efficacy is directly related to the amount of PZP antigen adminis¬ tered (Henderson et ai, 1988) and to the resulting antibody titres (Millar et al, 1989) , and ovarian dysfunction may likewise be related to PZP dose.
The purity of the PZP antigen may be a second factor in the possible alteration of ovarian function. Most of the early studies with rabbits, dogs and some non-human primates which demon¬ strated ovarian dysfunction used crude preparations of PZP, which included the entire complement of zonae protein. These various preparations also include associated carbohydrate moieties which are thought to be important antigenic components (Paterson & Aitken, 1990) . More recent studies have used preparations of higher purity and even genetically engineered epitopes of the ZP3 protein. Dunbar et al. (1989) used both ZP1 and ZP3, which share a common antigenic epitope, but serious ovarian dysfunction still occurred in baboons after 49 weeks and nine cycles. The horses in this study received crude PZP antigen which may have exacerbated long-term effects despite the small dose of 65 µg.
The duration of treatment may contribute to long-term effects. Small doses of high purity may produce long-term effects through cumulative effects upon follicular pools. No other mammals, apart from the horses in this study, have been treated with PZP for 3 years. Thus, our current understanding of long-term effects is poor. Based on the work of Liu et al. (1989) with captive mares, and the initial field tests with feral mares (Kirkpatrick et ai, 1990a (Kirkpatrick et ai, , 1991 , all of which used the same antigen and doses and demonstrated a return to normal fertility, the data from three consecutive years of treatment suggest that the duration of treatment may be the primary factor for this observed ovarian dysfunction in mares.
